Ara DMAP

Drug Profile

Ara DMAP

Alternative Names: 6-dimethylaminopurine arabinoside; CRU 550; NSC 407371

Latest Information Update: 05 Jan 2009

Price : $50

At a glance

  • Originator GlaxoSmithKline
  • Class Antivirals; Arabinonucleosides; Purine nucleosides; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Varicella zoster virus infections

Most Recent Events

  • 22 Jan 2001 Glaxo Wellcome has merged with SmithKline Beecham to form GlaxoSmithKline
  • 16 May 1996 Preclinical development for Varicella zoster virus infections in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top